IBDEI1L4 ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,28127,2)
 ;;=^57012
 ;;^UTILITY(U,$J,358.3,28128,0)
 ;;=053.9^^162^1792^38
 ;;^UTILITY(U,$J,358.3,28128,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28128,1,4,0)
 ;;=4^053.9
 ;;^UTILITY(U,$J,358.3,28128,1,5,0)
 ;;=5^Herpes Zoster NOS
 ;;^UTILITY(U,$J,358.3,28128,2)
 ;;=^56946
 ;;^UTILITY(U,$J,358.3,28129,0)
 ;;=487.1^^162^1792^41
 ;;^UTILITY(U,$J,358.3,28129,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28129,1,4,0)
 ;;=4^487.1
 ;;^UTILITY(U,$J,358.3,28129,1,5,0)
 ;;=5^Influenza
 ;;^UTILITY(U,$J,358.3,28129,2)
 ;;=^63125
 ;;^UTILITY(U,$J,358.3,28130,0)
 ;;=487.0^^162^1792^42
 ;;^UTILITY(U,$J,358.3,28130,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28130,1,4,0)
 ;;=4^487.0
 ;;^UTILITY(U,$J,358.3,28130,1,5,0)
 ;;=5^Influenza w/ Pneumonia
 ;;^UTILITY(U,$J,358.3,28130,2)
 ;;=^269942
 ;;^UTILITY(U,$J,358.3,28131,0)
 ;;=386.30^^162^1792^43
 ;;^UTILITY(U,$J,358.3,28131,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28131,1,4,0)
 ;;=4^386.30
 ;;^UTILITY(U,$J,358.3,28131,1,5,0)
 ;;=5^Labyrinthitis NOS
 ;;^UTILITY(U,$J,358.3,28131,2)
 ;;=^67891
 ;;^UTILITY(U,$J,358.3,28132,0)
 ;;=088.81^^162^1792^45
 ;;^UTILITY(U,$J,358.3,28132,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28132,1,4,0)
 ;;=4^088.81
 ;;^UTILITY(U,$J,358.3,28132,1,5,0)
 ;;=5^Lyme Disease
 ;;^UTILITY(U,$J,358.3,28132,2)
 ;;=^72315
 ;;^UTILITY(U,$J,358.3,28133,0)
 ;;=785.6^^162^1792^46
 ;;^UTILITY(U,$J,358.3,28133,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28133,1,4,0)
 ;;=4^785.6
 ;;^UTILITY(U,$J,358.3,28133,1,5,0)
 ;;=5^Lymphadenopathy
 ;;^UTILITY(U,$J,358.3,28133,2)
 ;;=^72368
 ;;^UTILITY(U,$J,358.3,28134,0)
 ;;=031.0^^162^1792^47
 ;;^UTILITY(U,$J,358.3,28134,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28134,1,4,0)
 ;;=4^031.0
 ;;^UTILITY(U,$J,358.3,28134,1,5,0)
 ;;=5^Mycobacteria,Atyp,Pulmonary
 ;;^UTILITY(U,$J,358.3,28134,2)
 ;;=^101018
 ;;^UTILITY(U,$J,358.3,28135,0)
 ;;=730.00^^162^1792^49
 ;;^UTILITY(U,$J,358.3,28135,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28135,1,4,0)
 ;;=4^730.00
 ;;^UTILITY(U,$J,358.3,28135,1,5,0)
 ;;=5^Osteomyelitis,Acute Unsp
 ;;^UTILITY(U,$J,358.3,28135,2)
 ;;=^272612
 ;;^UTILITY(U,$J,358.3,28136,0)
 ;;=730.10^^162^1792^50
 ;;^UTILITY(U,$J,358.3,28136,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28136,1,4,0)
 ;;=4^730.10
 ;;^UTILITY(U,$J,358.3,28136,1,5,0)
 ;;=5^Osteomyelitis,Chron Unsp
 ;;^UTILITY(U,$J,358.3,28136,2)
 ;;=^24427
 ;;^UTILITY(U,$J,358.3,28137,0)
 ;;=380.10^^162^1792^51
 ;;^UTILITY(U,$J,358.3,28137,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28137,1,4,0)
 ;;=4^380.10
 ;;^UTILITY(U,$J,358.3,28137,1,5,0)
 ;;=5^Otitis Externa 
 ;;^UTILITY(U,$J,358.3,28137,2)
 ;;=380.10^62807
 ;;^UTILITY(U,$J,358.3,28138,0)
 ;;=382.9^^162^1792^52
 ;;^UTILITY(U,$J,358.3,28138,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28138,1,4,0)
 ;;=4^382.9
 ;;^UTILITY(U,$J,358.3,28138,1,5,0)
 ;;=5^Otitis Media
 ;;^UTILITY(U,$J,358.3,28138,2)
 ;;=^123967
 ;;^UTILITY(U,$J,358.3,28139,0)
 ;;=614.9^^162^1792^53
 ;;^UTILITY(U,$J,358.3,28139,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28139,1,4,0)
 ;;=4^614.9
 ;;^UTILITY(U,$J,358.3,28139,1,5,0)
 ;;=5^Pelvic Inflammatory Disease
 ;;^UTILITY(U,$J,358.3,28139,2)
 ;;=^3537
 ;;^UTILITY(U,$J,358.3,28140,0)
 ;;=486.^^162^1792^55
 ;;^UTILITY(U,$J,358.3,28140,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28140,1,4,0)
 ;;=4^486.
 ;;^UTILITY(U,$J,358.3,28140,1,5,0)
 ;;=5^Pneumonia
 ;;^UTILITY(U,$J,358.3,28140,2)
 ;;=^95632
 ;;^UTILITY(U,$J,358.3,28141,0)
 ;;=136.3^^162^1792^54
 ;;^UTILITY(U,$J,358.3,28141,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28141,1,4,0)
 ;;=4^136.3
 ;;
 ;;$END ROU IBDEI1L4
